14 Nov Research grant winners to be announced at the Wisconsin Early Stage Symposium
Thirty-six companies will be recognized at the Wisconsin Early Stage Symposium as recipients of federal SBIR research grants, which are aimed at promoting commercial use of academic research and development.
Twelve of the 36 companies are located at University Research Park, including:
- AlgaXperts
- AmebaGone
- C-Motive Technologies
- Flugen
- Glucan Biorenewables
- InvivoSciences
- Lynx Biosciences
- PhylloTech
- Pointcare Genomics
- Stemina Biomarker Discovery
- Stratatech
- Xylome
Research grant winners to be honored at Wisconsin Early Stage Symposium
Thirty-six companies that won a combined $19.2 million in competitive federal research grants will be honored Wednesday during a luncheon at the 2016 Wisconsin Early Stage Symposium.
The companies, which are developing products in sectors that range from medical therapies to advanced materials, and from electric motors to sustainable wood products, will receive awards during the conference at Madison’s Monona Terrace Convention Center.
Dr. Lynn Allen-Hoffman, founder of Stratatech, will speak during the luncheon. Stratatech is a human skin replacement company in Madison recently acquired by Mallinckrodt, a pharmaceutical company based in the United Kingdom.
Companies that reported winning Small Business Innovation Research awards in the most recent year are: Advanced Engines Development Corp.; AlgaXperts LLC; AmebaGone Inc.; BellBrook Labs LLC; Cadens LLC; Cell Reprogramming and Therapeutics LLC; Centaur Systems Inc.; C-Motive Technologies Inc.; CompuTherm LLC; ConsortiEX Inc.; Fiberstar Bio-Ingredient Technologies Inc.; FlexCompute Inc.; Flugen Inc.; Glucan Biorenewables LLC; HealthMyne Inc.; Insert Inc.; Intact Solutions; Intelligent Composites LLC; Intraband LLC; InvivoSciences Inc.; Lucigen; Lynx Biosciences; Metria Innovation Inc.; PhylloTech LLC; Platypus Technologies LLC; Pointcare Genomics Corp.; Promentis Pharmaceuticals Inc.; Protein Foundry LLC; SHINE Medical Technologies Inc.; Stemina Biomarker Discovery Inc.; Stratatech Corp.; systeMECH LLC; Thalchemy Corp.; WholeTrees Architecture & Structures; WinnowGen Inc.; and Xylome Corp.
Created in 1982 to spur commercial use of academic research and development, SBIR grants are typically awarded to about one of 10 applicants. In order to be eligible for an SBIR award, for-profit businesses must be American-owned and independently operated, employ the principal researcher of the technology being developed, and have 500 or fewer employees.
The three-stage program is coordinated by the U.S. Small Business Administration, but grants originate with 11 federal agencies.
The companies, which are developing products in sectors that range from medical therapies to advanced materials, and from electric motors to sustainable wood products, will receive awards during the conference at Madison’s Monona Terrace Convention Center.
Dr. Lynn Allen-Hoffman, founder of Stratatech, will speak during the luncheon. Stratatech is a human skin replacement company in Madison recently acquired by Mallinckrodt, a pharmaceutical company based in the United Kingdom.
Companies that reported winning Small Business Innovation Research awards in the most recent year are: Advanced Engines Development Corp.; AlgaXperts LLC; AmebaGone Inc.; BellBrook Labs LLC; Cadens LLC; Cell Reprogramming and Therapeutics LLC; Centaur Systems Inc.; C-Motive Technologies Inc.; CompuTherm LLC; ConsortiEX Inc.; Fiberstar Bio-Ingredient Technologies Inc.; FlexCompute Inc.; Flugen Inc.; Glucan Biorenewables LLC; HealthMyne Inc.; Insert Inc.; Intact Solutions; Intelligent Composites LLC; Intraband LLC; InvivoSciences Inc.; Lucigen; Lynx Biosciences; Metria Innovation Inc.; PhylloTech LLC; Platypus Technologies LLC; Pointcare Genomics Corp.; Promentis Pharmaceuticals Inc.; Protein Foundry LLC; SHINE Medical Technologies Inc.; Stemina Biomarker Discovery Inc.; Stratatech Corp.; systeMECH LLC; Thalchemy Corp.; WholeTrees Architecture & Structures; WinnowGen Inc.; and Xylome Corp.
Created in 1982 to spur commercial use of academic research and development, SBIR grants are typically awarded to about one of 10 applicants. In order to be eligible for an SBIR award, for-profit businesses must be American-owned and independently operated, employ the principal researcher of the technology being developed, and have 500 or fewer employees.
The three-stage program is coordinated by the U.S. Small Business Administration, but grants originate with 11 federal agencies.